1. Factors limiting tumoricidal function of interferon-induced effector systems

   • Richard M. Schultz

   Short Review Pages: 61 - 66

2. Evaluation of antibody inhibition assays of melanoma antigens in sera to monitor tumor growth in melanoma patients

   • Peter Hersey
   • Elaine Murray
   • William H. McCarthy

   Original Articles Pages: 67 - 74

3. Suppressor cell activity in mice bearing a progressively growing Simian virus 40-induced sarcoma

   • Martin L. Padarathsingh
   • Jack H. Dean
   • Lloyd W. Law

   Original Articles Pages: 75 - 85

4. Resistance factors to intralesional immunotherapy with BCG or Corynebacterium parvum in rat tumors

   • Jean-Claude Salomon
   • Neil R. Lynch
   • Janine Prin

   Original Articles Pages: 87 - 97

5. Tumour-associated immunoglobulins and host cell infiltration

   • K. James
   • R. T. Cullen
   • K. Moore

   Original Articles Pages: 99 - 104

6. Effects of a thymic hormone, THF, on tumor-bearing mice and tumor-resected mice

   • A. Gabizon
   • N. Trainin

   Original Articles Pages: 105 - 111

7. Effects of four agents that modify microtubules and microfilaments (vinblastine, colchicine, lidocaine, and cytochalasin B) on macrophage-mediated cytotoxicity to tumor cells

   • François Martin
   • Nils-Olivier Olsson
   • Jean-François Jeannin

   Original Articles Pages: 113 - 119

8. Expression of surface antigens and its relation to parameters of malignancy in human malignant melanoma

   • Josef Brüggen
   • Egon Macher
   • Clemens Sorg

   Original Articles Pages: 121 - 127

9. Early side effects of intrathoracic BCG therapy in patients with stage I squamous cell carcinoma, adenocarcinoma, or large cell lung cancer

   • Mitchell H. Gail
   • Robert K. Oldham
   • Lung Cancer Study Group

   Original Articles Pages: 129 - 137

10. In vitro studies of the natural humoral antitumor reactivity of BALB/c and C57BL/6J mice

    • Sylvie Ménard
    • Maria Ines Colnaghi

    Original Articles Pages: 139 - 146

11. Prevention by the MER tubercle bacillus fraction of immunosuppression induced by cancer chemotherapeutic agents

    • Chava Zimber
    • Shlomo Ben-Efraim
    • David W. Weiss

    Original Articles Pages: 147 - 155

12. Toxicity studies of liposome-encapsulated immunomodulators administered intravenously to dogs and mice

    • Ian R. Hart
    • William E. Fogler
    • Isaiah J. Fidler

    Original Articles Pages: 157 - 166

13. Leukocyte adherence inhibition with HT-29 cells and primary colorectal carcinoma

    • Moshe Schmidt
    • Gerald Fruchter
    • Doreen Babott

    Letter To The Editor Pages: 167 - 168

14. HLA and testicular cancer

    • P. Aiginger
    • H. P. Schwarz
    • W. R. Mayr

    Letter To The Editor Pages: 169 - 170